Evaluation of the Electronic Adverse Drug Event Management System

Journal of Experimental and Clinical Medicine

Volumn 2, Issue 6, 2010, Pages 287-291

  Yen, Yu Hsuan ^a   Kuo, Li Na ^a   Hsu, Min Huei ^a   Li, Yu Chuan ^b   Cheng, Kuei Ju ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adverse drug events; Adverse drug events management; Electronic adverse drug management system

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DIAGNOSTIC AGENT; GASTROINTESTINAL AGENT; NEUROLEPTIC AGENT; TUBERCULOSTATIC AGENT;

ARTICLE; AUTOMATION; CHI SQUARE TEST; COMPARATIVE STUDY; COMPUTER SYSTEM; DISEASE SEVERITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ELECTRONIC ADVERSE DRUG EVENT MANAGEMENT SYSTEM; HEALTH CARE PERSONNEL; HOSPITAL; HUMAN; INFORMATION SYSTEM; INTRANET; PHARMACIST; UNSPECIFIED SIDE EFFECT;

EID: 78650199748     PISSN: 18783317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jecm.2010.10.002     Document Type: Article

References (20)

1. Ortega A., Aguinagalde A., Lacasa C., Aquerreta I., Fernandez-Benitez M., Fernandez L.M. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system. Ann Pharmacother 2008, 42:1491-1496.
2. Lee S.B., Schepers G.P., Goldberg K.L. Electronic adverse-drug-reaction-reporting program. Am J Health Syst Pharm 2004, 61. 1230, 1232-3.
3. Kunac D.L., Harrison-Woolrych M., Tatley M.V. Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use. N Z Med J 2008, 121:76-89.
4. Jha A.K., Kuperman G.J., Rittenberg E., Teich J.M., Bates D.W. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001, 10:113-119.
5. Jha A.K., Kuperman G.J., Teich J.M., Leape L., Shea B., Rittenberg E., Burdick E., et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998, 5:305-314.
6. Leape L.L., Cullen D.J., Clapp M.D., Burdick E., Demonaco H.J., Erickson J.I., Bates D.W. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999, 282:267-270.
7. Schnipper J.L., Kirwin J.L., Cotugno M.C., Wahlstrom S.A., Brown B.A., Tarvin E., Kachalia A., et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006, 166:565-571.
8. Murray M.D., Ritchey M.E., Wu J., Tu W. Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease. Arch Intern Med 2009, 169:757-763.
9. Anderson J.G., Jay S.J., Anderson M., Hunt T.J. Evaluating the capability of information technology to prevent adverse drug events: a computer simulation approach. J Am Med Inform Assoc 2002, 9:479-490.
10. Hope C., Overhage J.M., Seger A., Teal E., Mills V., Fiskio J., Gandhi T.K., et al. A tiered approach is more cost effective than traditional pharmacist-based review for classifying computer-detected signals as adverse drug events. J Biomed Inform 2003, 36:92-98.
11. Hwang S.H., Lee S., Koo H.K., Kim Y. Evaluation of a computer-based adverse-drug-event monitor. Am J Health Syst Pharm 2008, 65:2265-2272.
12. Rothschild J.M., Federico F.A., Gandhi T.K., Kaushal R., Williams D.H., Bates D.W. Analysis of medication-related malpractice claims: causes, preventability, and costs. Arch Intern Med 2002, 162:2414-2420.
13. Gandhi T.K., Weingart S.N., Borus J., Seger A.C., Peterson J., Burdick E., Seger D.L., et al. Adverse drug events in ambulatory care. N Engl J Med 2003, 348:1556-1564.
14. Bates D.W., Leape L.L., Cullen D.J., Laird N., Petersen L.A., Teich J.M., Burdick E., et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998, 280:1311-1316.
15. Wu J.H., Shen W.S., Lin L.M., Greenes R.A., Bates D.W. Testing the technology acceptance model for evaluating healthcare professionals' intention to use an adverse event reporting system. Int J Qual Health Care 2008, 20:123-129.
16. Dukes M.N.G., Aronson J.K. Meyler's Side Effects of Drugs 2000, Elsevier, Amsterdam, 638-55 and 1527--37.
17. Thurmann P.A. Methods and systems to detect adverse drug reactions in hospitals. Drug Saf 2001, 24:961-968.
18. Kilbridge P.M., Campbell U.C., Cozart H.B., Mojarrad M.G. Automated surveillance for adverse drug events at a community hospital and an academic medical center. J Am Med Inform Assoc 2006, 13:372-377.
19. Ye X., Fu Z., Wang H., Du W., Wang R., Sun Y., Gao Q., et al. A computerized system for signal detection in spontaneous reporting system of Shanghai China. Pharmacoepidemiol Drug Saf 2009, 18:154-158.
20. Waller P.C. Making the most of spontaneous adverse drug reaction reporting. Basic Clin Pharmacol Toxicol 2006, 98:320-323.